| Product Code: ETC9959163 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Alternative Medicines and Therapies Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Alternative Medicines and Therapies Market - Industry Life Cycle |
3.4 United States (US) Alternative Medicines and Therapies Market - Porter's Five Forces |
3.5 United States (US) Alternative Medicines and Therapies Market Revenues & Volume Share, By Intervention Type, 2021 & 2031F |
3.6 United States (US) Alternative Medicines and Therapies Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 United States (US) Alternative Medicines and Therapies Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.8 United States (US) Alternative Medicines and Therapies Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 United States (US) Alternative Medicines and Therapies Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 United States (US) Alternative Medicines and Therapies Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United States (US) Alternative Medicines and Therapies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing consumer interest in natural and holistic health approaches |
4.2.2 Growing awareness about the benefits of alternative medicines and therapies |
4.2.3 Rising healthcare costs leading individuals to explore more affordable treatment options |
4.3 Market Restraints |
4.3.1 Lack of regulation and standardization in the alternative medicines and therapies market |
4.3.2 Limited insurance coverage for alternative treatments |
4.3.3 Skepticism and resistance from traditional medical practitioners |
5 United States (US) Alternative Medicines and Therapies Market Trends |
6 United States (US) Alternative Medicines and Therapies Market, By Types |
6.1 United States (US) Alternative Medicines and Therapies Market, By Intervention Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Intervention Type, 2021- 2031F |
6.1.3 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Homeopathic Medicine, 2021- 2031F |
6.1.4 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Herbal Medicine, 2021- 2031F |
6.1.5 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Traditional Chinese Medicine, 2021- 2031F |
6.1.6 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Ayurveda Medicine, 2021- 2031F |
6.1.7 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Alternative Medicines and Therapies Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Chronic Diseases, 2021- 2031F |
6.2.3 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Neurological Diseases, 2021- 2031F |
6.2.4 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Reducing Pain, 2021- 2031F |
6.2.5 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By CNS Disorders, 2021- 2031F |
6.2.6 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Alternative Medicines and Therapies Market, By Therapy Type |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Magnetic Therapy, 2021- 2031F |
6.3.3 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Herbal Therapy, 2021- 2031F |
6.3.4 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Yoga Therapy, 2021- 2031F |
6.3.5 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Alternative Medicines and Therapies Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Tablets, 2021- 2031F |
6.4.3 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Powder, 2021- 2031F |
6.4.4 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Syrup, 2021- 2031F |
6.4.5 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Capsules and Others, 2021- 2031F |
6.5 United States (US) Alternative Medicines and Therapies Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Topical and Others, 2021- 2031F |
6.6 United States (US) Alternative Medicines and Therapies Market, By End Users |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.5 United States (US) Alternative Medicines and Therapies Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Alternative Medicines and Therapies Market Import-Export Trade Statistics |
7.1 United States (US) Alternative Medicines and Therapies Market Export to Major Countries |
7.2 United States (US) Alternative Medicines and Therapies Market Imports from Major Countries |
8 United States (US) Alternative Medicines and Therapies Market Key Performance Indicators |
8.1 Number of licensed alternative medicine practitioners in the US |
8.2 Adoption rate of alternative therapies by mainstream healthcare providers |
8.3 Research funding allocated to alternative medicine studies and clinical trials |
9 United States (US) Alternative Medicines and Therapies Market - Opportunity Assessment |
9.1 United States (US) Alternative Medicines and Therapies Market Opportunity Assessment, By Intervention Type, 2021 & 2031F |
9.2 United States (US) Alternative Medicines and Therapies Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 United States (US) Alternative Medicines and Therapies Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.4 United States (US) Alternative Medicines and Therapies Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 United States (US) Alternative Medicines and Therapies Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 United States (US) Alternative Medicines and Therapies Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United States (US) Alternative Medicines and Therapies Market - Competitive Landscape |
10.1 United States (US) Alternative Medicines and Therapies Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Alternative Medicines and Therapies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here